APO Research
Talk to an analyst

APO RESEARCH · REPORT

Progestin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Progestin Market Analysis and Forecast 2026-2032

2 January 2026193 pages

Choose your research edition.

Industry ResearchProgestin Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Progestin Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Progestin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Progestin Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Progestin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Progestin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Progestin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Progestin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Progestin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Progestin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Progestin include Zhejiang Medicine, Zhejiang Xianju Pharmaceutical, Zhejiang Aisheng Pharmaceutical, Teva Generics, Merck, Virtus Pharmaceuticals, LLC, BionPharma and Besins Healthcare, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Progestin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Progestin, also provides the sales of main regions and countries. Of the upcoming market potential for Progestin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Progestin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Progestin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Progestin sales, projected growth trends, production technology, application and end-user industry.

Progestin Segment by Company

Zhejiang Medicine

Zhejiang Xianju Pharmaceutical

Zhejiang Aisheng Pharmaceutical

Teva Generics

Merck

Virtus Pharmaceuticals, LLC

BionPharma

Besins Healthcare

Progestin Segment by Type

Progestin Oral

Progestin Injection

Progestin Suspended/Gel

Progestin Segment by Application

Pharmacies & Drug Stores

Hospital

Clinic

Progestin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Progestin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Progestin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Progestin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Progestin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Progestin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Progestin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Progestin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Progestin Oral Major Manufacturers Table 3. Progestin Injection Major Manufacturers Table 4. Progestin Suspended/Gel Major Manufacturers Table 5. Global Progestin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Pharmacies & Drug Stores Major Manufacturers Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Progestin Industry Trends Table 10. Progestin Industry Drivers Table 11. Progestin Industry Opportunities and Challenges Table 12. Progestin Industry Restraints Table 13. Global Progestin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Progestin Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Progestin Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Progestin Revenue Market Share by Region (2021-2026) Table 17. Global Progestin Revenue Market Share by Region (2027-2032) Table 18. Global Progestin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Progestin Sales by Region (2021-2026) & (K Units) Table 20. Global Progestin Sales by Region (2027-2032) & (K Units) Table 21. Global Progestin Sales Market Share by Region (2021-2026) Table 22. Global Progestin Sales Market Share by Region (2027-2032) Table 23. Global Progestin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Progestin Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Progestin Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Progestin Sales Market Share by Manufacturers (2021-2026) Table 27. Global Progestin Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Progestin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Progestin Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Progestin Manufacturers, Product Type & Application Table 31. Global Progestin Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Progestin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Progestin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Progestin Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Progestin Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Progestin Revenue Market Share by Type (2021-2026) Table 38. Global Progestin Revenue Market Share by Type (2027-2032) Table 39. Global Progestin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Progestin Sales by Type (2021-2026) & (K Units) Table 41. Global Progestin Sales by Type (2027-2032) & (K Units) Table 42. Global Progestin Sales Market Share by Type (2021-2026) Table 43. Global Progestin Sales Market Share by Type (2027-2032) Table 44. Global Progestin Price by Type (2021-2026) & (US$/Unit) Table 45. Global Progestin Price by Type (2027-2032) & (US$/Unit) Table 46. Global Progestin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Progestin Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Progestin Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Progestin Revenue Market Share by Application (2021-2026) Table 50. Global Progestin Revenue Market Share by Application (2027-2032) Table 51. Global Progestin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Progestin Sales by Application (2021-2026) & (K Units) Table 53. Global Progestin Sales by Application (2027-2032) & (K Units) Table 54. Global Progestin Sales Market Share by Application (2021-2026) Table 55. Global Progestin Sales Market Share by Application (2027-2032) Table 56. Global Progestin Price by Application (2021-2026) & (US$/Unit) Table 57. Global Progestin Price by Application (2027-2032) & (US$/Unit) Table 58. Zhejiang Medicine Company Information Table 59. Zhejiang Medicine Business Overview Table 60. Zhejiang Medicine Progestin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Zhejiang Medicine Progestin Product Portfolio Table 62. Zhejiang Medicine Recent Development Table 63. Zhejiang Xianju Pharmaceutical Company Information Table 64. Zhejiang Xianju Pharmaceutical Business Overview Table 65. Zhejiang Xianju Pharmaceutical Progestin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Zhejiang Xianju Pharmaceutical Progestin Product Portfolio Table 67. Zhejiang Xianju Pharmaceutical Recent Development Table 68. Zhejiang Aisheng Pharmaceutical Company Information Table 69. Zhejiang Aisheng Pharmaceutical Business Overview Table 70. Zhejiang Aisheng Pharmaceutical Progestin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Zhejiang Aisheng Pharmaceutical Progestin Product Portfolio Table 72. Zhejiang Aisheng Pharmaceutical Recent Development Table 73. Teva Generics Company Information Table 74. Teva Generics Business Overview Table 75. Teva Generics Progestin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Teva Generics Progestin Product Portfolio Table 77. Teva Generics Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Progestin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Merck Progestin Product Portfolio Table 82. Merck Recent Development Table 83. Virtus Pharmaceuticals, LLC Company Information Table 84. Virtus Pharmaceuticals, LLC Business Overview Table 85. Virtus Pharmaceuticals, LLC Progestin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Virtus Pharmaceuticals, LLC Progestin Product Portfolio Table 87. Virtus Pharmaceuticals, LLC Recent Development Table 88. BionPharma Company Information Table 89. BionPharma Business Overview Table 90. BionPharma Progestin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. BionPharma Progestin Product Portfolio Table 92. BionPharma Recent Development Table 93. Besins Healthcare Company Information Table 94. Besins Healthcare Business Overview Table 95. Besins Healthcare Progestin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Besins Healthcare Progestin Product Portfolio Table 97. Besins Healthcare Recent Development Table 98. North America Progestin Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Progestin Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Progestin Sales by Type (2021-2026) & (K Units) Table 101. North America Progestin Sales by Type (2027-2032) & (K Units) Table 102. North America Progestin Sales Price by Type (2021-2026) & (US$/Unit) Table 103. North America Progestin Sales Price by Type (2027-2032) & (US$/Unit) Table 104. North America Progestin Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Progestin Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Progestin Sales by Application (2021-2026) & (K Units) Table 107. North America Progestin Sales by Application (2027-2032) & (K Units) Table 108. North America Progestin Sales Price by Application (2021-2026) & (US$/Unit) Table 109. North America Progestin Sales Price by Application (2027-2032) & (US$/Unit) Table 110. North America Progestin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Progestin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Progestin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Progestin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 114. North America Progestin Sales by Country (2021-2026) & (K Units) Table 115. North America Progestin Sales by Country (2027-2032) & (K Units) Table 116. North America Progestin Sales Price by Country (2021-2026) & (US$/Unit) Table 117. North America Progestin Sales Price by Country (2027-2032) & (US$/Unit) Table 118. United States Progestin Revenue (2021-2032) & (US$ Million) Table 119. Canada Progestin Revenue (2021-2032) & (US$ Million) Table 120. Europe Progestin Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Progestin Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Progestin Sales by Type (2021-2026) & (K Units) Table 123. Europe Progestin Sales by Type (2027-2032) & (K Units) Table 124. Europe Progestin Sales Price by Type (2021-2026) & (US$/Unit) Table 125. Europe Progestin Sales Price by Type (2027-2032) & (US$/Unit) Table 126. Europe Progestin Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Progestin Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Progestin Sales by Application (2021-2026) & (K Units) Table 129. Europe Progestin Sales by Application (2027-2032) & (K Units) Table 130. Europe Progestin Sales Price by Application (2021-2026) & (US$/Unit) Table 131. Europe Progestin Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Europe Progestin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Progestin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Europe Progestin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Europe Progestin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 136. Europe Progestin Sales by Country (2021-2026) & (K Units) Table 137. Europe Progestin Sales by Country (2027-2032) & (K Units) Table 138. Europe Progestin Sales Price by Country (2021-2026) & (US$/Unit) Table 139. Europe Progestin Sales Price by Country (2027-2032) & (US$/Unit) Table 140. Germany Progestin Revenue (2021-2032) & (US$ Million) Table 141. France Progestin Revenue (2021-2032) & (US$ Million) Table 142. U.K. Progestin Revenue (2021-2032) & (US$ Million) Table 143. Italy Progestin Revenue (2021-2032) & (US$ Million) Table 144. Netherlands Progestin Revenue (2021-2032) & (US$ Million) Table 145. China Progestin Revenue by Type (2021-2026) & (US$ Million) Table 146. China Progestin Revenue by Type (2027-2032) & (US$ Million) Table 147. China Progestin Sales by Type (2021-2026) & (K Units) Table 148. China Progestin Sales by Type (2027-2032) & (K Units) Table 149. China Progestin Sales Price by Type (2021-2026) & (US$/Unit) Table 150. China Progestin Sales Price by Type (2027-2032) & (US$/Unit) Table 151. China Progestin Revenue by Application (2021-2026) & (US$ Million) Table 152. China Progestin Revenue by Application (2027-2032) & (US$ Million) Table 153. China Progestin Sales by Application (2021-2026) & (K Units) Table 154. China Progestin Sales by Application (2027-2032) & (K Units) Table 155. China Progestin Sales Price by Application (2021-2026) & (US$/Unit) Table 156. China Progestin Sales Price by Application (2027-2032) & (US$/Unit) Table 157. Asia Progestin Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Progestin Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Progestin Sales by Type (2021-2026) & (K Units) Table 160. Asia Progestin Sales by Type (2027-2032) & (K Units) Table 161. Asia Progestin Sales Price by Type (2021-2026) & (US$/Unit) Table 162. Asia Progestin Sales Price by Type (2027-2032) & (US$/Unit) Table 163. Asia Progestin Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Progestin Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Progestin Sales by Application (2021-2026) & (K Units) Table 166. Asia Progestin Sales by Application (2027-2032) & (K Units) Table 167. Asia Progestin Sales Price by Application (2021-2026) & (US$/Unit) Table 168. Asia Progestin Sales Price by Application (2027-2032) & (US$/Unit) Table 169. Asia Progestin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Progestin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia Progestin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia Progestin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 173. Asia Progestin Sales by Country (2021-2026) & (K Units) Table 174. Asia Progestin Sales by Country (2027-2032) & (K Units) Table 175. Asia Progestin Sales Price by Country (2021-2026) & (US$/Unit) Table 176. Asia Progestin Sales Price by Country (2027-2032) & (US$/Unit) Table 177. Japan Progestin Revenue (2021-2032) & (US$ Million) Table 178. South Korea Progestin Revenue (2021-2032) & (US$ Million) Table 179. India Progestin Revenue (2021-2032) & (US$ Million) Table 180. Australia Progestin Revenue (2021-2032) & (US$ Million) Table 181. China Taiwan Progestin Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia Progestin Revenue (2021-2032) & (US$ Million) Table 183. SAMEA Progestin Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Progestin Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Progestin Sales by Type (2021-2026) & (K Units) Table 186. SAMEA Progestin Sales by Type (2027-2032) & (K Units) Table 187. SAMEA Progestin Sales Price by Type (2021-2026) & (US$/Unit) Table 188. SAMEA Progestin Sales Price by Type (2027-2032) & (US$/Unit) Table 189. SAMEA Progestin Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA Progestin Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA Progestin Sales by Application (2021-2026) & (K Units) Table 192. SAMEA Progestin Sales by Application (2027-2032) & (K Units) Table 193. SAMEA Progestin Sales Price by Application (2021-2026) & (US$/Unit) Table 194. SAMEA Progestin Sales Price by Application (2027-2032) & (US$/Unit) Table 195. SAMEA Progestin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Progestin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA Progestin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA Progestin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 199. SAMEA Progestin Sales by Country (2021-2026) & (K Units) Table 200. SAMEA Progestin Sales by Country (2027-2032) & (K Units) Table 201. SAMEA Progestin Sales Price by Country (2021-2026) & (US$/Unit) Table 202. SAMEA Progestin Sales Price by Country (2027-2032) & (US$/Unit) Table 203. Brazil Progestin Revenue (2021-2032) & (US$ Million) Table 204. Argentina Progestin Revenue (2021-2032) & (US$ Million) Table 205. Chile Progestin Revenue (2021-2032) & (US$ Million) Table 206. Colombia Progestin Revenue (2021-2032) & (US$ Million) Table 207. Peru Progestin Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia Progestin Revenue (2021-2032) & (US$ Million) Table 209. Israel Progestin Revenue (2021-2032) & (US$ Million) Table 210. UAE Progestin Revenue (2021-2032) & (US$ Million) Table 211. Turkey Progestin Revenue (2021-2032) & (US$ Million) Table 212. Iran Progestin Revenue (2021-2032) & (US$ Million) Table 213. Egypt Progestin Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Progestin Distributors List Table 217. Progestin Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Progestin Image Figure 2. Global Progestin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Progestin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Progestin Oral Image Figure 5. Progestin Injection Image Figure 6. Progestin Suspended/Gel Image Figure 7. Global Progestin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Progestin Market Size Share 2021 VS 2025 VS 2032 Figure 9. Pharmacies & Drug Stores Image Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Global Progestin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Progestin Revenue (2021-2032) & (US$ Million) Figure 14. Global Progestin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Progestin Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Progestin Revenue Market Share by Region (2021-2032) Figure 17. Global Progestin Sales (2021-2032) & (K Units) Figure 18. Global Progestin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Progestin Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Progestin Sales YoY (2021-2032) & (K Units) Figure 21. Europe Progestin Sales YoY (2021-2032) & (K Units) Figure 22. China Progestin Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Progestin Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Progestin Sales YoY (2021-2032) & (K Units) Figure 25. Global Progestin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Progestin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Progestin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Progestin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Progestin Revenue Market Share by Type (2021-2032) Figure 31. Global Progestin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Progestin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Progestin Sales Market Share by Type (2021-2032) Figure 34. Global Progestin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Progestin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Progestin Revenue Market Share by Application (2021-2032) Figure 37. Global Progestin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Progestin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Progestin Sales Market Share by Application (2021-2032) Figure 40. North America Progestin Revenue Share by Type (2021-2032) Figure 41. North America Progestin Sales Share by Type (2021-2032) Figure 42. North America Progestin Revenue Share by Application (2021-2032) Figure 43. North America Progestin Sales Share by Application (2021-2032) Figure 44. North America Progestin Revenue Share by Country (2021-2032) Figure 45. North America Progestin Sales Share by Country (2021-2032) Figure 46. Europe Progestin Revenue Share by Type (2021-2032) Figure 47. Europe Progestin Sales Share by Type (2021-2032) Figure 48. Europe Progestin Revenue Share by Application (2021-2032) Figure 49. Europe Progestin Sales Share by Application (2021-2032) Figure 50. Europe Progestin Revenue Share by Country (2021-2032) Figure 51. Europe Progestin Sales Share by Country (2021-2032) Figure 52. China Progestin Revenue Share by Type (2021-2032) Figure 53. China Progestin Sales Share by Type (2021-2032) Figure 54. China Progestin Revenue Share by Application (2021-2032) Figure 55. China Progestin Sales Share by Application (2021-2032) Figure 56. Asia Progestin Revenue Share by Type (2021-2032) Figure 57. Asia Progestin Sales Share by Type (2021-2032) Figure 58. Asia Progestin Revenue Share by Application (2021-2032) Figure 59. Asia Progestin Sales Share by Application (2021-2032) Figure 60. Asia Progestin Revenue Share by Country (2021-2032) Figure 61. Asia Progestin Sales Share by Country (2021-2032) Figure 62. SAMEA Progestin Revenue Share by Type (2021-2032) Figure 63. SAMEA Progestin Sales Share by Type (2021-2032) Figure 64. SAMEA Progestin Revenue Share by Application (2021-2032) Figure 65. SAMEA Progestin Sales Share by Application (2021-2032) Figure 66. SAMEA Progestin Revenue Share by Country (2021-2032) Figure 67. SAMEA Progestin Sales Share by Country (2021-2032) Figure 68. Progestin Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Progestin Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Progestin Oral
  • Progestin Injection
  • Progestin Suspended/Gel
Applications
  • Pharmacies & Drug Stores
  • Hospital
  • Clinic
Companies covered
  • Zhejiang Medicine
  • Zhejiang Xianju Pharmaceutical
  • Zhejiang Aisheng Pharmaceutical
  • Teva Generics
  • Merck
  • Virtus Pharmaceuticals, LLC
  • BionPharma
  • Besins Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Progestin Market by Type
  3. 1.2.1 Global Progestin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Progestin Oral
  5. 1.2.3 Progestin Injection
  6. 1.2.4 Progestin Suspended/Gel
  7. 1.3 Progestin Market by Application
  8. 1.3.1 Global Progestin Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmacies & Drug Stores
  10. 1.3.3 Hospital
  11. 1.3.4 Clinic
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Progestin Market Dynamics
  1. 2.1 Progestin Industry Trends
  2. 2.2 Progestin Industry Drivers
  3. 2.3 Progestin Industry Opportunities and Challenges
  4. 2.4 Progestin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Progestin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Progestin Revenue by Region
  3. 3.2.1 Global Progestin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Progestin Revenue by Region (2021-2026)
  5. 3.2.3 Global Progestin Revenue by Region (2027-2032)
  6. 3.2.4 Global Progestin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Progestin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Progestin Sales by Region
  9. 3.4.1 Global Progestin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Progestin Sales by Region (2021-2026)
  11. 3.4.3 Global Progestin Sales by Region (2027-2032)
  12. 3.4.4 Global Progestin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Progestin Revenue by Manufacturers
  2. 4.1.1 Global Progestin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Progestin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Progestin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Progestin Sales by Manufacturers
  6. 4.2.1 Global Progestin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Progestin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Progestin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Progestin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Progestin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Progestin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Progestin Manufacturers, Product Type & Application
  13. 4.7 Global Progestin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Progestin Market CR5 and HHI
  16. 4.8.2 2025 Progestin Tier 1, Tier 2, and Tier 3
5 Progestin Market by Type
  1. 5.1 Global Progestin Revenue by Type
  2. 5.1.1 Global Progestin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Progestin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Progestin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Progestin Sales by Type
  6. 5.2.1 Global Progestin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Progestin Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Progestin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Progestin Price by Type
6 Progestin Market by Application
  1. 6.1 Global Progestin Revenue by Application
  2. 6.1.1 Global Progestin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Progestin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Progestin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Progestin Sales by Application
  6. 6.2.1 Global Progestin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Progestin Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Progestin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Progestin Price by Application
7 Company Profiles
  1. 7.1 Zhejiang Medicine
  2. 7.1.1 Zhejiang Medicine Company Information
  3. 7.1.2 Zhejiang Medicine Business Overview
  4. 7.1.3 Zhejiang Medicine Progestin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zhejiang Medicine Progestin Product Portfolio
  6. 7.1.5 Zhejiang Medicine Recent Developments
  7. 7.2 Zhejiang Xianju Pharmaceutical
  8. 7.2.1 Zhejiang Xianju Pharmaceutical Company Information
  9. 7.2.2 Zhejiang Xianju Pharmaceutical Business Overview
  10. 7.2.3 Zhejiang Xianju Pharmaceutical Progestin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Zhejiang Xianju Pharmaceutical Progestin Product Portfolio
  12. 7.2.5 Zhejiang Xianju Pharmaceutical Recent Developments
  13. 7.3 Zhejiang Aisheng Pharmaceutical
  14. 7.3.1 Zhejiang Aisheng Pharmaceutical Company Information
  15. 7.3.2 Zhejiang Aisheng Pharmaceutical Business Overview
  16. 7.3.3 Zhejiang Aisheng Pharmaceutical Progestin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Zhejiang Aisheng Pharmaceutical Progestin Product Portfolio
  18. 7.3.5 Zhejiang Aisheng Pharmaceutical Recent Developments
  19. 7.4 Teva Generics
  20. 7.4.1 Teva Generics Company Information
  21. 7.4.2 Teva Generics Business Overview
  22. 7.4.3 Teva Generics Progestin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Teva Generics Progestin Product Portfolio
  24. 7.4.5 Teva Generics Recent Developments
  25. 7.5 Merck
  26. 7.5.1 Merck Company Information
  27. 7.5.2 Merck Business Overview
  28. 7.5.3 Merck Progestin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merck Progestin Product Portfolio
  30. 7.5.5 Merck Recent Developments
  31. 7.6 Virtus Pharmaceuticals, LLC
  32. 7.6.1 Virtus Pharmaceuticals, LLC Company Information
  33. 7.6.2 Virtus Pharmaceuticals, LLC Business Overview
  34. 7.6.3 Virtus Pharmaceuticals, LLC Progestin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Virtus Pharmaceuticals, LLC Progestin Product Portfolio
  36. 7.6.5 Virtus Pharmaceuticals, LLC Recent Developments
  37. 7.7 BionPharma
  38. 7.7.1 BionPharma Company Information
  39. 7.7.2 BionPharma Business Overview
  40. 7.7.3 BionPharma Progestin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 BionPharma Progestin Product Portfolio
  42. 7.7.5 BionPharma Recent Developments
  43. 7.8 Besins Healthcare
  44. 7.8.1 Besins Healthcare Company Information
  45. 7.8.2 Besins Healthcare Business Overview
  46. 7.8.3 Besins Healthcare Progestin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Besins Healthcare Progestin Product Portfolio
  48. 7.8.5 Besins Healthcare Recent Developments
8 North America
  1. 8.1 North America Progestin Market Size by Type
  2. 8.1.1 North America Progestin Revenue by Type (2021-2032)
  3. 8.1.2 North America Progestin Sales by Type (2021-2032)
  4. 8.1.3 North America Progestin Price by Type (2021-2032)
  5. 8.2 North America Progestin Market Size by Application
  6. 8.2.1 North America Progestin Revenue by Application (2021-2032)
  7. 8.2.2 North America Progestin Sales by Application (2021-2032)
  8. 8.2.3 North America Progestin Price by Application (2021-2032)
  9. 8.3 North America Progestin Market Size by Country
  10. 8.3.1 North America Progestin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Progestin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Progestin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Progestin Market Size by Type
  2. 9.1.1 Europe Progestin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Progestin Sales by Type (2021-2032)
  4. 9.1.3 Europe Progestin Price by Type (2021-2032)
  5. 9.2 Europe Progestin Market Size by Application
  6. 9.2.1 Europe Progestin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Progestin Sales by Application (2021-2032)
  8. 9.2.3 Europe Progestin Price by Application (2021-2032)
  9. 9.3 Europe Progestin Market Size by Country
  10. 9.3.1 Europe Progestin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Progestin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Progestin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Progestin Market Size by Type
  2. 10.1.1 China Progestin Revenue by Type (2021-2032)
  3. 10.1.2 China Progestin Sales by Type (2021-2032)
  4. 10.1.3 China Progestin Price by Type (2021-2032)
  5. 10.2 China Progestin Market Size by Application
  6. 10.2.1 China Progestin Revenue by Application (2021-2032)
  7. 10.2.2 China Progestin Sales by Application (2021-2032)
  8. 10.2.3 China Progestin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Progestin Market Size by Type
  2. 11.1.1 Asia Progestin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Progestin Sales by Type (2021-2032)
  4. 11.1.3 Asia Progestin Price by Type (2021-2032)
  5. 11.2 Asia Progestin Market Size by Application
  6. 11.2.1 Asia Progestin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Progestin Sales by Application (2021-2032)
  8. 11.2.3 Asia Progestin Price by Application (2021-2032)
  9. 11.3 Asia Progestin Market Size by Country
  10. 11.3.1 Asia Progestin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Progestin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Progestin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Progestin Market Size by Type
  2. 12.1.1 SAMEA Progestin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Progestin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Progestin Price by Type (2021-2032)
  5. 12.2 SAMEA Progestin Market Size by Application
  6. 12.2.1 SAMEA Progestin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Progestin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Progestin Price by Application (2021-2032)
  9. 12.3 SAMEA Progestin Market Size by Country
  10. 12.3.1 SAMEA Progestin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Progestin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Progestin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Progestin Value Chain Analysis
  2. 13.1.1 Progestin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Progestin Production Mode & Process
  6. 13.2 Progestin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Progestin Distributors
  9. 13.2.3 Progestin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst